US FDA Approves Corcept’s Lifyorli For A Broad Ovarian Cancer Population

First Drug Of Its Kind Cleared To Treat Cancer

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.